nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—TYMS—cleft lip	0.888	1	CbGaD
Raltitrexed—FPGS—Metabolism of folate and pterines—SLC19A1—cleft lip	0.0329	0.325	CbGpPWpGaD
Raltitrexed—TYMS—One Carbon Metabolism—MTHFS—cleft lip	0.0108	0.107	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism of folate and pterines—MTHFR—cleft lip	0.0101	0.0999	CbGpPWpGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—cleft lip	0.00536	0.0529	CbGpPWpGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—TCN2—cleft lip	0.00444	0.0438	CbGpPWpGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TYMS—cleft lip	0.0041	0.0404	CbGpPWpGaD
Raltitrexed—TYMS—One Carbon Metabolism—TCN2—cleft lip	0.00401	0.0396	CbGpPWpGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—MTHFR—cleft lip	0.00358	0.0353	CbGpPWpGaD
Raltitrexed—Pralatrexate—SLC19A1—cleft lip	0.00319	0.311	CrCbGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—MTR—cleft lip	0.00308	0.0304	CbGpPWpGaD
Raltitrexed—TYMS—One Carbon Metabolism—MTR—cleft lip	0.00278	0.0274	CbGpPWpGaD
Raltitrexed—TYMS—Trans-sulfuration and one carbon metabolism—MTR—cleft lip	0.0025	0.0247	CbGpPWpGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cleft lip	0.00165	0.0163	CbGpPWpGaD
Raltitrexed—TYMS—One Carbon Metabolism—MTHFR—cleft lip	0.00149	0.0147	CbGpPWpGaD
Raltitrexed—Methotrexate—SLC19A1—cleft lip	0.00141	0.137	CrCbGaD
Raltitrexed—Tetrahydrofolic acid—MTR—cleft lip	0.00139	0.135	CrCbGaD
Raltitrexed—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—cleft lip	0.00134	0.0132	CbGpPWpGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—MTHFR—cleft lip	0.00131	0.0129	CbGpPWpGaD
Raltitrexed—Pralatrexate—TYMS—cleft lip	0.000927	0.0903	CrCbGaD
Raltitrexed—Leucovorin—TYMS—cleft lip	0.000927	0.0903	CrCbGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.000863	0.00852	CbGpPWpGaD
Raltitrexed—FPGS—Disease—WNT9B—cleft lip	0.000778	0.00768	CbGpPWpGaD
Raltitrexed—Pemetrexed—TYMS—cleft lip	0.000741	0.0722	CrCbGaD
Raltitrexed—FPGS—Disease—ABCA4—cleft lip	0.000694	0.00685	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SLC19A1—cleft lip	0.000635	0.00626	CbGpPWpGaD
Raltitrexed—FPGS—Disease—WNT3—cleft lip	0.000618	0.0061	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—SLC19A1—cleft lip	0.000531	0.00524	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TCN2—cleft lip	0.000526	0.00519	CbGpPWpGaD
Raltitrexed—Folic Acid—MTHFR—cleft lip	0.000475	0.0463	CrCbGaD
Raltitrexed—Tetrahydrofolic acid—MTHFR—cleft lip	0.000475	0.0463	CrCbGaD
Raltitrexed—FPGS—Metabolism—TCN2—cleft lip	0.00044	0.00435	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGF7—cleft lip	0.000409	0.00404	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SPRY2—cleft lip	0.000409	0.00404	CbGpPWpGaD
Raltitrexed—Methotrexate—TYMS—cleft lip	0.000409	0.0398	CrCbGaD
Raltitrexed—FPGS—Disease—FGF8—cleft lip	0.000377	0.00372	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTR—cleft lip	0.000364	0.0036	CbGpPWpGaD
Raltitrexed—Methotrexate—MTHFR—cleft lip	0.000325	0.0317	CrCbGaD
Raltitrexed—TYMS—E2F transcription factor network—MYC—cleft lip	0.00032	0.00316	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.00031	0.00306	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGF3—cleft lip	0.000307	0.00303	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—MTR—cleft lip	0.000305	0.00301	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGF9—cleft lip	0.0003	0.00296	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—cleft lip	0.000278	0.00274	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGF10—cleft lip	0.000253	0.00249	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—MYC—cleft lip	0.000232	0.00229	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000227	0.00224	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGFR2—cleft lip	0.000203	0.002	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—cleft lip	0.000195	0.00193	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTHFR—cleft lip	0.000195	0.00193	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC19A1—cleft lip	0.000194	0.00191	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGFR1—cleft lip	0.000189	0.00186	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—TYMS—cleft lip	0.000187	0.00185	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGFR3—cleft lip	0.000179	0.00176	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—MTHFR—cleft lip	0.000163	0.00161	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—TCN2—cleft lip	0.000161	0.00158	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000148	0.00146	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGF2—cleft lip	0.000138	0.00136	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NOS3—cleft lip	0.000136	0.00134	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NOS3—cleft lip	0.000114	0.00112	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTR—cleft lip	0.000111	0.0011	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—cleft lip	9.02e-05	0.00089	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—cleft lip	7.17e-05	0.000708	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—cleft lip	6.41e-05	0.000633	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTHFR—cleft lip	5.96e-05	0.000588	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NOS3—cleft lip	4.16e-05	0.00041	CbGpPWpGaD
